| 1 |
Bernitsa S, Dayan R, Stephanou A, Tzvetanova ID, Patrikios IS. Natural biomolecules and derivatives as anticancer immunomodulatory agents. Front Immunol 2022;13:1070367. [PMID: 36700235 DOI: 10.3389/fimmu.2022.1070367] [Reference Citation Analysis]
|
| 2 |
Modi S, Giri B, Gupta VK, Lavania S, Sethi V, Sharma NS, Pandey S, Vickers S, Dudeja V, Saluja AK. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215591] [Reference Citation Analysis]
|
| 3 |
Oteyola AO, Pilla R, Ola-oladimeji FA, Fagbuaro O. Natural Products Application and Combination Therapy in Colorectal Cancer Treatment. Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics 2022. [DOI: 10.4018/978-1-7998-9258-8.ch004] [Reference Citation Analysis]
|
| 4 |
Li G, Li H, Lyu Y, Zeng W, Zhou J. Enhanced Biosynthesis of Dihydromyricetin in Saccharomyces cerevisiae by Coexpression of Multiple Hydroxylases. J Agric Food Chem 2020;68:14221-9. [DOI: 10.1021/acs.jafc.0c05261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 5 |
Viegas JSR, Praça FG, Kravicz M, Bentley MVLB. Therapeutic applications and delivery systems for triptolide. Drug Deliv and Transl Res 2020;10:1584-600. [DOI: 10.1007/s13346-020-00827-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, Zhao M, Liu Q, Cheng Z, Zou J, Yao P, Gao C, Wei J, Ung COL, Wang S, Zhong Z, Wang Y. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med 2019;14:48. [PMID: 31719837 DOI: 10.1186/s13020-019-0270-9] [Cited by in Crossref: 145] [Cited by in F6Publishing: 160] [Article Influence: 36.3] [Reference Citation Analysis]
|
| 7 |
Li C, Li Z, Zhang T, Wei P, Li N, Zhang W, Ding X, Li J. 1H NMR-Based Metabolomics Reveals the Antitumor Mechanisms of Triptolide in BALB/c Mice Bearing CT26 Tumors. Front Pharmacol 2019;10:1175. [PMID: 31680959 DOI: 10.3389/fphar.2019.01175] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Wang X, Zheng M, Fei F, Li C, Du J, Liu K, Li Y, Zhang S. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment. Med Oncol 2019;36:82. [PMID: 31407170 DOI: 10.1007/s12032-019-1303-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Deng Y, Guo L, Cai H, Chen L, Tan S, Zhang B, Fang P, Xiang D, Li H, He G, Yan M. Dihydromyricetin affect the pharmacokinetics of triptolide in rats. Xenobiotica 2020;50:332-8. [PMID: 31092113 DOI: 10.1080/00498254.2019.1616851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Ma Z, Fan Y, Wu Y, Kebebe D, Zhang B, Lu P, Pi J, Liu Z. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment. Int J Nanomedicine 2019;14:2029-53. [PMID: 30962686 DOI: 10.2147/IJN.S197889] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 11 |
Yao C, Li H, Zhang W. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218. Int J Immunopathol Pharmacol 2018;32:2058738418812349. [PMID: 30453799 DOI: 10.1177/2058738418812349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Hou Z, Tong X, Peng Y, Zhang B, Yan M. Broad targeting of triptolide to resistance and sensitization for cancer therapy. Biomedicine & Pharmacotherapy 2018;104:771-80. [DOI: 10.1016/j.biopha.2018.05.088] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 13 |
Chen SR, Dai Y, Zhao J, Lin L, Wang Y, Wang Y. A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F. Front Pharmacol 2018;9:104. [PMID: 29491837 DOI: 10.3389/fphar.2018.00104] [Cited by in Crossref: 152] [Cited by in F6Publishing: 161] [Article Influence: 30.4] [Reference Citation Analysis]
|
| 14 |
Gao H, Zhang Y, Dong L, Qu XY, Tao LN, Zhang YM, Zhai JH, Song YQ. Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells. Exp Ther Med 2018;15:3413-9. [PMID: 29545863 DOI: 10.3892/etm.2018.5830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 15 |
Liu Y, Bi T, Wang Z, Wu G, Qian L, Gao Q, Shen G. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway. Apoptosis 2016;21:1398-407. [PMID: 27671687 DOI: 10.1007/s10495-016-1297-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 16 |
Bahrami A, Khazaei M, Hasanzadeh M, ShahidSales S, Joudi Mashhad M, Farazestanian M, Sadeghnia HR, Rezayi M, Maftouh M, Hassanian SM, Avan A. Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress. J Cell Biochem. 2018;119:2460-2469. [PMID: 28230287 DOI: 10.1002/jcb.25950] [Cited by in Crossref: 75] [Cited by in F6Publishing: 88] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 17 |
Redondo-Blanco S, Fernández J, Gutiérrez-Del-Río I, Villar CJ, Lombó F. New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds. Front Pharmacol 2017;8:109. [PMID: 28352231 DOI: 10.3389/fphar.2017.00109] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 18 |
Zhang H, Gong C, Qu L, Ding X, Cao W, Chen H, Zhang B, Zhou G. Therapeutic effects of triptolide via the inhibition of IL-1β expression in a mouse model of ulcerative colitis. Exp Ther Med 2016;12:1279-86. [PMID: 27588050 DOI: 10.3892/etm.2016.3490] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 19 |
Modi S, Kir D, Giri B, Majumder K, Arora N, Dudeja V, Banerjee S, Saluja AK. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer. J Gastrointest Surg 2016;20:13-23; discussion 23-4. [PMID: 26503259 DOI: 10.1007/s11605-015-3000-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 20 |
Ho J, Byun S, Lee S, Oh JJ, Hong SK, Lee SE, Yeon JS. Synergistic Antitumor Effect of Triptolide and Cisplatin in Cisplatin Resistant Human Bladder Cancer Cells. Journal of Urology 2015;193:1016-22. [DOI: 10.1016/j.juro.2014.09.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 21 |
Meng G, Wang W, Chai K, Yang S, Li F, Jiang K. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways. Int J Oncol 2015;46:1007-17. [PMID: 25573072 DOI: 10.3892/ijo.2015.2814] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 22 |
Meng C, Zhu H, Song H, Wang Z, Huang G, Li D, Ma Z, Ma J, Qin Q, Sun X, Ma J. Targets and molecular mechanisms of triptolide in cancer therapy. Chin J Cancer Res 2014;26:622-6. [PMID: 25400429 DOI: 10.3978/j.issn.1000-9604.2014.09.01] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
|
